Výsledky vyhľadávania - "Sterling, Timothy"

  1. 1

    Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy Autor Bourgi, Kassem, Rebeiro, Peter F, Turner, Megan, Castilho, Jessica L, Hulgan, Todd, Raffanti, Stephen P, Koethe, John R, Sterling, Timothy R

    ISSN: 1537-6591, 1537-6591
    Vydavateľské údaje: United States 17.03.2020
    Vydané v Clinical infectious diseases (17.03.2020)
    “…Recent studies have reported weight gain in virologically suppressed persons living with human immunodeficiency virus (PLWH) switched from older antiretroviral…”
    Zistit podrobnosti o prístupe
    Journal Article
  2. 2
  3. 3
  4. 4

    Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis Autor Suthar, Amitabh B., Lawn, Stephen D., del Amo, Julia, Getahun, Haileyesus, Dye, Christopher, Sculier, Delphine, Sterling, Timothy R., Chaisson, Richard E., Williams, Brian G., Harries, Anthony D., Granich, Reuben M.

    ISSN: 1549-1676, 1549-1277, 1549-1676
    Vydavateľské údaje: United States Public Library of Science 01.07.2012
    Vydané v PLoS medicine (01.07.2012)
    “…Human immunodeficiency virus (HIV) infection is the strongest risk factor for developing tuberculosis and has fuelled its resurgence, especially in sub-Saharan…”
    Získať plný text
    Journal Article
  5. 5
  6. 6

    Treatment of Latent Tuberculosis Infection-An Update Autor Huaman, Moises A, Sterling, Timothy R

    ISSN: 1557-8216, 1557-8216
    Vydavateľské údaje: United States 01.12.2019
    Vydané v Clinics in chest medicine (01.12.2019)
    “…Treatment of latent tuberculosis infection (LTBI) is an important component of TB control and elimination. LTBI treatment regimens include once-weekly…”
    Zistit podrobnosti o prístupe
    Journal Article
  7. 7

    Treatment of latent M. tuberculosis infection and use of antiretroviral therapy to prevent tuberculosis Autor Sterling, Timothy R., Lin, Philana Ling

    ISSN: 0021-9738, 1558-8238, 1558-8238
    Vydavateľské údaje: United States American Society for Clinical Investigation 01.10.2020
    Vydané v The Journal of clinical investigation (01.10.2020)
    “…Even with treatment of HIV with antiretroviral therapy (ART), the risk of tuberculosis (TB) reactivation remains higher in HIV-infected than HIV-uninfected…”
    Získať plný text
    Journal Article
  8. 8
  9. 9

    Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa Autor Pietersen, Elize, Anderson, Kim, Cox, Helen, Dheda, Keertan, Bian, Aihua, Shepherd, Bryan E., Sterling, Timothy R., Warren, Robin M., van der Heijden, Yuri F.

    ISSN: 1932-6203, 1932-6203
    Vydavateľské údaje: United States Public Library of Science 13.02.2023
    Vydané v PloS one (13.02.2023)
    “…Updated World Health Organization (WHO) treatment guidelines prioritize all-oral drug-resistant tuberculosis (DR-TB) regimens. Several poorly tolerated drugs,…”
    Získať plný text
    Journal Article
  10. 10

    Diagnostic biomarkers for active tuberculosis: progress and challenges Autor Nogueira, Betânia M F, Krishnan, Sonya, Barreto‐Duarte, Beatriz, Araújo‐Pereira, Mariana, Queiroz, Artur T L, Ellner, Jerrold J, Salgame, Padmini, Scriba, Thomas J, Sterling, Timothy R, Gupta, Amita, Andrade, Bruno B

    ISSN: 1757-4676, 1757-4684, 1757-4684
    Vydavateľské údaje: London Nature Publishing Group UK 07.12.2022
    Vydané v EMBO molecular medicine (07.12.2022)
    “…Tuberculosis (TB) is a leading cause of morbidity and mortality from a single infectious agent, despite being preventable and curable. Early and accurate…”
    Získať plný text
    Journal Article
  11. 11

    Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru Autor Villegas, Leonela, Otero, Larissa, Sterling, Timothy R., Huaman, Moises A., Van der Stuyft, Patrick, Gotuzzo, Eduardo, Seas, Carlos

    ISSN: 1932-6203, 1932-6203
    Vydavateľské údaje: United States Public Library of Science 05.04.2016
    Vydané v PloS one (05.04.2016)
    “…Isoniazid and rifampicin are the two most efficacious first-line agents for tuberculosis (TB) treatment. We assessed the prevalence of isoniazid and rifampicin…”
    Získať plný text
    Journal Article
  12. 12

    Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection Autor Sterling, Timothy R, Villarino, M. Elsa, Borisov, Andrey S, Shang, Nong, Gordin, Fred, Bliven-Sizemore, Erin, Hackman, Judith, Hamilton, Carol Dukes, Menzies, Dick, Kerrigan, Amy, Weis, Stephen E, Weiner, Marc, Wing, Diane, Conde, Marcus B, Bozeman, Lorna, Horsburgh, C. Robert, Chaisson, Richard E

    ISSN: 0028-4793, 1533-4406, 1533-4406
    Vydavateľské údaje: Waltham, MA Massachusetts Medical Society 08.12.2011
    Vydané v The New England journal of medicine (08.12.2011)
    “…Treatment of latent TB is an important public-health strategy, but 9 months of daily isoniazid (270 doses) poses challenges for compliance. In this study, 3…”
    Získať plný text
    Journal Article
  13. 13

    Tuberculosis Meningitis Autor Bourgi, Kassem, Fiske, Christina, Sterling, Timothy R.

    ISSN: 1523-3847, 1534-3146
    Vydavateľské údaje: New York Springer US 01.11.2017
    Vydané v Current infectious disease reports (01.11.2017)
    “…Purpose of Review As the most severe form of tuberculosis (TB), TB meningitis disproportionately affects developing countries and results in significant…”
    Získať plný text
    Journal Article
  14. 14

    CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy Autor Castilho, Jessica L, Shepherd, Bryan E, Koethe, John, Turner, Megan, Bebawy, Sally, Logan, James, Rogers, William B, Raffanti, Stephen, Sterling, Timothy R

    ISSN: 1473-5571, 1473-5571
    Vydavateľské údaje: England 27.03.2016
    Vydané v AIDS (London) (27.03.2016)
    “…In virologically suppressed HIV-infected adults, noncommunicable diseases (NCDs) have been associated with immune senescence and low CD4/CD8 lymphocyte ratio…”
    Zistit podrobnosti o prístupe
    Journal Article
  15. 15

    Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid Autor Villarino, M Elsa, Scott, Nigel A, Weis, Stephen E, Weiner, Marc, Conde, Marcus B, Jones, Brenda, Nachman, Sharon, Oliveira, Ricardo, Moro, Ruth N, Shang, Nong, Goldberg, Stefan V, Sterling, Timothy R

    ISSN: 2168-6211, 2168-6211
    Vydavateľské údaje: United States 01.03.2015
    Vydané v JAMA pediatrics (01.03.2015)
    “…Three months of a once-weekly combination of rifapentine and isoniazid for treatment of latent tuberculosis infection is safe and effective for persons 12…”
    Zistit podrobnosti o prístupe
    Journal Article
  16. 16
  17. 17

    Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults Autor Peetluk, Lauren S., Ridolfi, Felipe M., Rebeiro, Peter F., Liu, Dandan, Rolla, Valeria C, Sterling, Timothy R.

    ISSN: 2044-6055, 2044-6055
    Vydavateľské údaje: England British Medical Journal Publishing Group 02.03.2021
    Vydané v BMJ open (02.03.2021)
    “…ObjectiveTo systematically review and critically evaluate prediction models developed to predict tuberculosis (TB) treatment outcomes among adults with…”
    Získať plný text
    Journal Article
  18. 18
  19. 19

    A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system Autor Maruri, Fernanda, Sterling, Timothy R, Kaiga, Anne W, Blackman, Amondrea, van der Heijden, Yuri F, Mayer, Claudine, Cambau, Emmanuelle, Aubry, Alexandra

    ISSN: 1460-2091, 1460-2091
    Vydavateľské údaje: England 01.04.2012
    Vydané v Journal of antimicrobial chemotherapy (01.04.2012)
    “…Fluoroquinolone resistance in Mycobacterium tuberculosis has become increasingly important. A review of mutations in DNA gyrase, the fluoroquinolone target, is…”
    Zistit podrobnosti o prístupe
    Journal Article
  20. 20

    Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection Autor Mehaffy, Carolina, Kruh-Garcia, Nicole A, Graham, Barbara, Jarlsberg, Leah G, Willyerd, Charis E, Borisov, Andrey, Sterling, Timothy R, Nahid, Payam, Dobos, Karen M

    ISSN: 1098-660X, 1098-660X
    Vydavateľské údaje: United States 26.05.2020
    Vydané v Journal of clinical microbiology (26.05.2020)
    “…Identification of biomarkers for latent infection and risk of progression to tuberculosis (TB) disease are needed to better identify individuals to target for…”
    Zistit podrobnosti o prístupe
    Journal Article